-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qj4BHz2U2xgFehA1SOKpSJQOnPPYmrAdycikKXt7EoLUiXLqLSqELrf0/vzq5bOg cpFiSjhwlGwlu548WpU75A== 0001144204-10-044745.txt : 20100816 0001144204-10-044745.hdr.sgml : 20100816 20100816165303 ACCESSION NUMBER: 0001144204-10-044745 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100630 FILED AS OF DATE: 20100816 DATE AS OF CHANGE: 20100816 EFFECTIVENESS DATE: 20100816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 IRS NUMBER: 830406777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12884 FILM NUMBER: 101020560 BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 v194149_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2010 Check here if Amendment [_]; Amendment Number: ___________ This Amendment (Check only one): [_] is a restatement. [_] adds new entries. Institutional Investment Manager Filing this Report: Name: RA Capital Management, LLC ------------------------------------- Address: 20 Park Plaza, Suite 905 ------------------------------------- Boston, MA 02116 ------------------------------------- Form 13F File Number: 28-12884 -------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter Kolchinsky ------------------------------------- Title: Manager ------------------------------------- Phone: (617) 778-2500 ------------------------------------- Signature, Place, and Date of Signing /s/ Peter Kolchinsky Boston, MA August 16, 2010 - -------------------------- -------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------------- Form 13F Information Tabel Entry Total: 26 ----------------- Form 13F Information Table Value Total: 99,025 ----------------- (thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - --------------------------- ------------ ----------- -------- ---------------------- ---------- -------- --------------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE/ SHARED/NONE - ------------------------------------------------------------------------------------------------------------------------------------ AASTROM BIOSCIENCES INC COM NEW 00253U 30 5 2,440 1,637,838 SH SOLE N/A 1,637,838 ALEXION PHARMACEUTICALS INC COM 015351 10 9 4,828 94,321 SH SOLE N/A 94,321 AMARIN CORP PLC SPONS ADR NEW 023111 20 6 2,360 947,715 SH SOLE N/A 947,715 AMERICAN ORIENTAL BIOENGR IN COM 028731 10 7 176 70,000 SH SOLE N/A 70,000 AMGEN INC COM 031162 10 0 5,219 99,214 SH SOLE N/A 99,214 ANADYS PHARMACEUTICALS INC COM 03252Q 40 8 179 93,285 SH SOLE N/A 93,285 ARTHROCARE CORP COM 043136 10 0 8,005 261,165 SH SOLE N/A 261,165 BIOSPECIFICS TECHNOLOGIES CO COM 090931 10 6 12,423 624,917 SH SOLE N/A 624,917 DENDREON CORP COM 24823Q 10 7 1,658 51,274 SH SOLE N/A 51,274 DEPOMED INC COM 249908 10 4 5,169 1,846,200 SH SOLE N/A 1,846,200 DYNAVAX TECHNOLOGIES CORP COM 268158 10 2 2,066 1,110,953 SH SOLE N/A 1,110,953 GENTIUM S P A SPONSORED ADR 37250B 10 4 1,293 284,712 SH SOLE N/A 284,712 GILEAD SCIENCES INC COM 375558 10 3 5,569 162,468 SH SOLE N/A 162,468 HUMAN GENOME SCIENCES INC COM 444903 10 8 6,186 273,000 SH SOLE N/A 273,000 ILLUMINA INC COM 452327 10 9 5,095 117,041 SH SOLE N/A 117,041 JAZZ PHARMACEUTICALS INC COM 472147 10 7 1,141 145,700 SH SOLE N/A 145,700 MELA SCIENCES INC COM 55277R 10 0 2,976 400,000 SH SOLE N/A 400,000 OREXIGEN THERAPEUTICS INC COM 686164 10 4 252 60,000 SH SOLE N/A 60,000 PHARMASSET INC COM 71715N 10 6 9,001 329,213 SH SOLE N/A 329,213 PSIVIDA CORP COM 74440J 10 1 3,245 898,911 SH SOLE N/A 898,911 SALIX PHARMACEUTICALS INC COM 795435 10 6 5,239 134,219 SH SOLE N/A 134,219 SANTARUS INC COM 802817 30 4 489 197,325 SH SOLE N/A 197,325 TARGACEPT INC COM 87611R 30 6 7,536 389,847 SH SOLE N/A 389,847 TELIK INC COM 87959M 10 9 1,663 2,131,665 SH SOLE N/A 2,131,665 TENGION INC COM 88034G 10 9 43 11,643 SH SOLE N/A 11,643 TEVA PHARMACEUTICAL INDS LTD ADR 881624 20 9 4,773 91,809 SH SOLE N/A 91,809
-----END PRIVACY-ENHANCED MESSAGE-----